289 related articles for article (PubMed ID: 30451032)
1. Glycomics of prostate cancer: updates.
Tkac J; Bertok T; Hires M; Jane E; Lorencova L; Kasak P
Expert Rev Proteomics; 2019 Jan; 16(1):65-76. PubMed ID: 30451032
[No Abstract] [Full Text] [Related]
2. Breast cancer glycan biomarkers: their link to tumour cell metabolism and their perspectives in clinical practice.
Bertok T; Pinkova Gajdosova V; Bertokova A; Svecova N; Kasak P; Tkac J
Expert Rev Proteomics; 2021 Oct; 18(10):881-910. PubMed ID: 34711108
[TBL] [Abstract][Full Text] [Related]
3. Glycans as Biomarkers in Prostate Cancer.
Scott E; Munkley J
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893936
[TBL] [Abstract][Full Text] [Related]
4. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of quantitative glycomics.
Peng W; Zhao J; Dong X; Banazadeh A; Huang Y; Hussien A; Mechref Y
Expert Rev Proteomics; 2018 Dec; 15(12):1007-1031. PubMed ID: 30380947
[TBL] [Abstract][Full Text] [Related]
6. The proteomics of prostate cancer exosomes.
Drake RR; Kislinger T
Expert Rev Proteomics; 2014 Apr; 11(2):167-77. PubMed ID: 24564711
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
[No Abstract] [Full Text] [Related]
8. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
9. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
[TBL] [Abstract][Full Text] [Related]
10. Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.
Nyalwidhe JO; Betesh LR; Powers TW; Jones EE; White KY; Burch TC; Brooks J; Watson MT; Lance RS; Troyer DA; Semmes OJ; Mehta A; Drake RR
Proteomics Clin Appl; 2013 Oct; 7(9-10):677-89. PubMed ID: 23775902
[TBL] [Abstract][Full Text] [Related]
11. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
12. A glycomics approach to the discovery of potential cancer biomarkers.
An HJ; Lebrilla CB
Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
[TBL] [Abstract][Full Text] [Related]
13. Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer.
Panigrahi GK; Deep G
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1682-1696. PubMed ID: 28410139
[TBL] [Abstract][Full Text] [Related]
14. Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation.
Wang L; Skotland T; Berge V; Sandvig K; Llorente A
Eur J Pharm Sci; 2017 Feb; 98():80-85. PubMed ID: 27664330
[TBL] [Abstract][Full Text] [Related]
15. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis.
Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Analysis of serum glycome by lectin microarrays for prostate cancer patients - a search for aberrant glycoforms.
Bertok T; Jane E; Chrenekova N; Hroncekova S; Bertokova A; Hires M; Vikartovska A; Kubanikova P; Sokol R; Fillo J; Kasak P; Borsig L; Tkac J
Glycoconj J; 2020 Dec; 37(6):703-711. PubMed ID: 33119808
[TBL] [Abstract][Full Text] [Related]
19. Lectin-based glycomics: how and when was the technology born?
Hirabayashi J
Methods Mol Biol; 2014; 1200():225-42. PubMed ID: 25117239
[TBL] [Abstract][Full Text] [Related]
20. Enrichment strategies in glycomics-based lung cancer biomarker development.
Ruhaak LR; Nguyen UT; Stroble C; Taylor SL; Taguchi A; Hanash SM; Lebrilla CB; Kim K; Miyamoto S
Proteomics Clin Appl; 2013 Oct; 7(9-10):664-76. PubMed ID: 23640812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
